title: Coronary stent implantation throughout technical evolution: immediate and follow-up results.
abstract: Coronary stenting (stent implantation) has evolved over the last 5 years with changes in stent design, stent material and the implantation technique. The use of high-pressure balloon inflation (HP), intravascular ultrasound (IVUS) and appropriate antiplatelet therapy have contributed to the abolishment of the need for subsequent anticoagulation, allowing extended stent applications. We compared results in three groups of patients having stent implantation throughout the period of evolution: group A: no IVUS, no HP, with subsequent anticoagulation treatment (n 3 434); group B: no IVUS, yes HP, without subsequent anticoagulation treatment (n 3 192); and group C: yes IVUS, yes HP, without subsequent anticoagulation treatment (n 3 588). The primary success rates were comparable in all groups. There was a clear change in indications for stenting in groups B and C compared with group A (elective stenting: group A 3 32%; group B 3 66%; group C 3 69%; P < 0.0001), in reference vessel size (group A 3 3.22 3 0.37 mm; group B 3 2.92 3 0.56 mm; group C 3 2.98 3 0.57 mm; P < 0.0001), and for presence of type B2 and C lesions (group A 3 57%; group B 3 72%; group C 3 74%; P < 0.001). The complication rate significantly decreased in group C (group A 3 3.6%; group B 3 4.1%; group C 3 1.2%; P < 0.001) and the mean patient hospital stay decreased to 2 days in groups B and C due to the abolition of the need for anticoagulant treatment. The angiographic restenosis rate increased in groups B and C (group A 3 20%; group B 3 34%; group C 3 32%; P < 0.001). The need for a repeat procedure increased as stenting of more complex lesions and smaller vessels was attempted: target lesion revascularization (TLR) was performed in 16% of patients in group A (73/434), in 18% of group B (35/192) and in 22% of group C (129/588) (P 3 0.04 for A versus C). Major cardiac events (MACE) occurred in 142 patients in group A (33%), 60 patients in group B (31%) and in 181 patients in group C (30%). The evolving technique of coronary stenting has expanded the spectrum of indications and range of coronary vessels attempted, and decreased the complication rates and hospital stay. However, in less-favorable subsets, additional improvements are needed to affect the long-term outcome.
authors.affiliation: Centro Cuore Columbus, Milano, Italy.
authors.forename: Leo
authors.initials: L
authors.lastname: Finci
authors.forename: Massimo
authors.initials: M
authors.lastname: Ferraro
authors.forename: Yoshio
authors.initials: Y
authors.lastname: Kobayashi
authors.forename: Joseph de
authors.lastname: Gregorio Jd
authors.forename: Issam
authors.initials: I
authors.lastname: Moussa
authors.forename: Remo
authors.initials: R
authors.lastname: Albiero
authors.forename: Lucia
authors.initials: L
authors.lastname: Di
authors.forename: Nobuyoshi
authors.initials: N
authors.lastname: Kobayashi
authors.forename: Giovanni
authors.initials: G
authors.lastname: Martini
authors.forename: Gina
authors.initials: G
authors.lastname: Tucci
authors.forename: Martino
authors.initials: M
authors.lastname: Recchia
authors.forename: Carlo
authors.initials: C
authors.lastname: Di Mario
authors.forename: Antonio
authors.initials: A
authors.lastname: Colombo